Kan Yuji, Sumikawa Yasuyuki, Hida Tokimasa, Ajiki Saeko, Uhara Hisashi
Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Eurasian J Med. 2020 Feb;52(1):103-105. doi: 10.5152/eurasianjmed.2019.19099.
In this case study, we aimed to evaluate the disease condition of patients with pustulotic arthro-osteitis (PAO) at 36-month post-tonsillectomy. A retrospective analysis of the cases of 17 patients with PAO who were resistant to initial systemic treatments and underwent tonsillectomy at our hospital in 2006-2016 was conducted. The patients' disease condition at 1-, 24-, and 36-month post-tonsillectomy was assessed by the visual analog scale (VAS) score for osteoarthropathic pain, the disease duration, the area of palmoplantar lesions, and the Palmoplantar Pustular Psoriasis Area Severity Index (ppPASI). In the minimum follow-up of 36-month post-tonsillectomy in 17 patients, the median ppPASI and VAS scores decreased from 12 to 1 and from 80 to 20, respectively. Thirteen patients with ≥70% improvement in their VAS scores maintained the same good condition after ≥36 months, whereas four patients with <70% improvement in their VAS scores did not show remarkable improvement after that time point. Furthermore, we found that the improvement in VAS score was not associated with the disease duration or the patients' pre-tonsillectomy ppPASI values. Tonsillectomy might be an alternative treatment option for patients with PAO. Long-term efficacy against pain can be predicted by evaluating a patient's improvement at 1-month post-tonsillectomy.
在本病例研究中,我们旨在评估扁桃体切除术后36个月时脓疱性关节骨炎(PAO)患者的疾病状况。对2006年至2016年在我院接受扁桃体切除术的17例对初始全身治疗耐药的PAO患者的病例进行了回顾性分析。通过骨关节炎疼痛视觉模拟量表(VAS)评分、病程、掌跖病变面积和掌跖脓疱性银屑病面积严重程度指数(ppPASI)评估患者在扁桃体切除术后1个月、24个月和36个月时的疾病状况。在对17例患者进行的扁桃体切除术后至少36个月的随访中,ppPASI和VAS评分中位数分别从12降至1、从80降至20。13例VAS评分改善≥70%的患者在≥36个月后保持了良好状态,而4例VAS评分改善<70%的患者在该时间点后未显示出明显改善。此外,我们发现VAS评分的改善与病程或患者扁桃体切除术前的ppPASI值无关。扁桃体切除术可能是PAO患者的一种替代治疗选择。通过评估患者在扁桃体切除术后1个月的改善情况,可以预测其对疼痛的长期疗效。